Translational Challenge

Antimicrobial Resistance

Home » Translational Challenges » Global Health » Antimicrobial Resistance

Tackling one of the top 10 global health threats.

Antimicrobial resistance could wipe out our ability to treat infections, leaving us exposed from even the most minor injuries or illnesses.

Like most global health challenges, drug-resistant infections are complex; different regions and countries face different obstacles. Low and middle-income countries are disproportionately affected.

10 million

people per year could lose their lives to AMR by 2050 (40% in Africa)

$3.5b USD

the cost per year on healthcare alone from 2015 to 2050 (World Bank)

What do we want to achieve?

We want to slow the emergence of resistant infections and reduce deaths from AMR by:

  • driving better use of existing treatments
  • developing new targeted therapies, including diagnostics
  • improving the ability to diagnose and treat resistant infections

How you can work with us

We collaborate and invest in efforts to:

Discover new antibacterials

Develop rapid, low-cost, point of care diagnostics

Better define the patient experience and unmet need

Understand the challenges faced by low and middle-income countries and help develop tailored solutions

See how we can work together
See available funding

Some of our partnerships and initiatives

PACE: Pathways to Antimicrobial Clinical Efficacy

A £30 million initiative with Innovate UK and Medicines Discovery Catapult, driving new developments to tackle antimicrobial resistance.

Read more

ReACT Africa

A project aimed at tackling antimicrobial resistance (AMR) in Zambia and Kenya.

Read more
Pharmacist holding medicine box and capsule pack in pharmacy drugstore.

TB-MBLA

LifeArc has partnered with the University of St Andrews in developing the TB-MBLA – ‘Tuberculosis Molecular Bacterial Load Assay.’

Read more
Pic Alan Richardson Dundee, Pix-AR.co.uk Free to Use from the University of St Andrews International Conference on tuberculosis School of Medicine

Who to contact

Get in touch

Other Global Health Translational Challenges

Neglected Tropical Diseases

Supporting the elimination and control of neglected tropical diseases. 

Read more

Emerging Viral Threats

Tackling established viruses and potential epidemics. 

Read more

Contact us

Name(Required)
Email(Required)
Please let us know what's on your mind. Have a question for us? Ask away.

In submitting your personal data via this form, you consent to being contacted via the details provided so that your enquiry can be responded to. If you would like your data to be removed, please email info@lifearc.org.

Please see our Privacy Policy in relation to the personal data you submit to us through this page.

Related stories

  • News releases

    ReAct Africa and LifeArc announce launch of ASPIRE initiative to combat antimicrobial resistance in Zambia and Kenya

    ReAct (Action on Antibiotic Resistance) Africa, in partnership with self-funded medical research organisation and charity LifeArc, is excited to introduce a pioneering effort…

    Read more

  • Pharmacist holding medicine box and capsule pack in pharmacy drugstore.
    News releases

    New UK-India research project trialling easy-to-use test to help fight against global threat of antimicrobial resistance

    A new UK-India research project, DOSA2, is trialling an easy-to-use test to determine if a urinary tract infection (UTI) is present to help…

    Read more

  • Pace: Pathways to Antimicrobial Clinical Efficacy cover image.
    News releases

    New £30m initiative to address global threat by accelerating the pace of antimicrobial innovation

    Pioneering partnership to drive development of new tests and treatments to tackle deadly antimicrobial resistance, which could otherwise kill 10 million a year…

    Read more